https://www.bu.edu/aodhealth/2014/03/01/barriers-and-facilitators-for-hcv-treatment-engagement-within-integrated-care-delivery-models/
Barriers and Facilitators for HCV Treatment Engagement within Integrated Care Delivery Models |...
barriers and facilitatorsintegrated care deliveryhcv treatment
https://www.biospace.com/viropharma-incorporated-and-wyeth-initiate-dosing-in-phase-2-study-of-hcv-796-in-treatment-naive-patients-and-non-responders
ViroPharma Incorporated And Wyeth Initiate Dosing In Phase 2 Study Of HCV-796 In Treatment Naive...
https://www.epo.org/en/boards-of-appeal/decisions/t131394eu1
T 1394/13 (Pre-treatment of HCV samples/ADVANCED LIFE SCIENCE INSTITUTE) of 19.09.2018